Evidence map›Paper›PMID 30929760›Full record

ArticleBritish journal of anaesthesia2019

Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity.

Abdella M Habib, Andrei L Okorokov, Matthew N Hill, Jose T Bras, Man-Cheung Lee, Shengnan Li, Samuel J Gossage, Marie van Drimmelen, Maria Morena, Henry Houlden and 4 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in British journal of anaesthesia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 122 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. The genetics of pain.BJA education · 2024
    Review
  9. Article
  10. Review
  11. Cutaneous Wound Healing and the Effects of Cannabidiol.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Frontiers in neuroinformatics · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Abdella M HabibMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, UK; College of Medicine, Member of Qatar Health Cluster, Qatar University, Doha, Qatar.
Andrei L OkorokovMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, UK.
Matthew N HillHotchkiss Brain Institute, Departments of Cell Biology and Anatomy and Psychiatry, University of Calgary, Calgary, AB, Canada.
Jose T BrasUK Dementia Research Institute at UCL, London, UK; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
Man-Cheung LeeMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, UK; University Division of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK; Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA, USA.
Shengnan LiMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, UK.
Samuel J GossageMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, UK.
Marie van DrimmelenDepartment of Pathology, Raigmore Hospital, Inverness, UK.
Maria MorenaHotchkiss Brain Institute, Departments of Cell Biology and Anatomy and Psychiatry, University of Calgary, Calgary, AB, Canada.
Henry HouldenDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
Juan D RamirezNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
David L H BennettNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Devjit SrivastavaDepartment of Anaesthesia, Raigmore Hospital, Inverness, UK. Electronic address: dev.srivastava@nhs.net.
James J CoxMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, UK. Electronic address: j.j.cox@ucl.ac.uk.
University College London · GBRaigmore Hospital · GBUniversity of Calgary · CAUniversity of Oxford · GBQatar University · QA

Funding

Medical Research Council G0802760Medical Research Council G1001253Medical Research Council G108/638Medical Research Council G1100340Medical Research Council MR/S01165X/1The Dunhill Medical Trust R605/0717Versus Arthritis 21950Wellcome Trust 200183/Z/15/ZWellcome Trust 202747/Z/16/Z
6 · The paper itself

Abstract

The study of rare families with inherited pain insensitivity can identify new human-validated analgesic drug targets. Here, a 66-yr-old female presented with nil requirement for postoperative analgesia after a normally painful orthopaedic hand surgery (trapeziectomy). Further investigations revealed a lifelong history of painless injuries, such as frequent cuts and burns, which were observed to heal quickly. We report the causative mutations for this new pain insensitivity disorder: the co-inheritance of (i) a microdeletion in dorsal root ganglia and brain-expressed pseudogene, FAAH-OUT, which we cloned from the fatty-acid amide hydrolase (FAAH) chromosomal region; and (ii) a common functional single-nucleotide polymorphism in FAAH conferring reduced expression and activity. Circulating concentrations of anandamide and related fatty-acid amides (palmitoylethanolamide and oleoylethanolamine) that are all normally degraded by FAAH were significantly elevated in peripheral blood compared with normal control carriers of the hypomorphic single-nucleotide polymorphism. The genetic findings and elevated circulating fatty-acid amides are consistent with a phenotype resulting from enhanced endocannabinoid signalling and a loss of function of FAAH. Our results highlight previously unknown complexity at the FAAH genomic locus involving the expression of FAAH-OUT, a novel pseudogene and long non-coding RNA. These data suggest new routes to develop FAAH-based analgesia by targeting of FAAH-OUT, which could significantly improve the treatment of postoperative pain and potentially chronic pain and anxiety disorders.

Indexed as

AgedAmidohydrolasesArachidonic AcidsEndocannabinoidsFatty Acid Amide HydrolasesFemaleHumansPain Insensitivity, CongenitalPolymorphism, Single NucleotidePolyunsaturated AlkamidesPseudogenesAmidohydrolasesanandamideArachidonic AcidsEndocannabinoidsFatty Acid Amide HydrolasesPolyunsaturated Alkamidesanandamideanxiolyticendocannabinoidspain insensitivitypostoperative analgesia

Identifiers

PMID30929760
PMCPMC6676009
OpenAlexW2923404145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.